Yahoo
NasdaqCM - Nasdaq Real Time Price USD

DataMEDS AI, Inc. (MEDS)

0.9845 -0.1955 (-16.57%)
At close: November 9 at 4:00:01 PM EST
1.0202 +0.0357 (+3.63%)
Pre-Market: 7:49:15 AM EST

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Prashant Patel M.Sc., R.Ph.
Interim Co-CEO, President & Director 13.38k -- 1974
Mr. Eric Michael Sherb CPA
Interim-CFO 182.03k -- 1987
Mr. Gerald E. Commissiong
Interim Co-Chief Executive Officer -- -- 1982
Mr. Brett Thompson
Chief Technology Officer -- -- --
Dr. Shafaat Pirani Pharm.D.
Chief Clinical Officer 275k -- 1989
Mr. Nikul Panchal BCNP, R.Ph.
Senior Vice President of Pharmacy -- -- 1977
Raj Mehta M.B.A., R.Ph.
SVP of Tech and Hub -- -- --

DataMEDS AI, Inc.

3000 Bayport Drive
Suite 950
Tampa, FL 33607
United States
844 203 6092 https://datamedsai.com
Sector: 
Healthcare
Industry: 
Medical Distribution

Description

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services. DataMEDS AI, Inc., through its subsidiary develops and delivers a portfolio of products to guide physicians and patients with difficult clinical decisions throughout the cancer care continuum. In addition, the company develops and provides functional precision medicine oncology platform. The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Corporate Governance

DataMEDS AI, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

November 5, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 26, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 20, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 16, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 13, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 9, 2026 at 12:00 AM UTC

PRE 14C: Proxy Statements

September 17, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 16, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 31, 2026 at 12:00 AM UTC

PRE 14C: Proxy Statements

August 18, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: